Transcriptome-derived stromal and immune scores infer clinical outcomes of patients with cancer.

导出 OA

翻译打印收藏纠错

作者： Wei,Liu ^[1] ; Hua,Ye ^[2] ; Ying-Fu,Liu ^[3] ; Chao-Qun,Xu ^[4] ; Yue-Xian,Zhong ^[1] ; Tian,Tian ^[1] ; Shi-Wei,Ma ^[1] ; Huan,Tao ^[1] ; Ling,Li ^[1] ; Li-Chun,Xue ^[1] ; Hua-Qin,He ^[1]

作者单位： School of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, Fujian 350002, P.R. China. ^[1] Department of Pathology, Human Centrifuge Medical Training Center, Institute of Aviation Medicine of Chinese PLA Air Force, Beijing 100089, P.R. China. ^[2] Department of Gastroenterology, Ningbo Medical Treatment Center Lihuili Hospital, Ningbo, Zhejiang 315040, P.R. China. ^[3] Department of Cell Biology, Logistics University of Chinese Armed Police Forces, Tianjin 300309, P.R. China. ^[4]

关键词 immune cells recurrence stromal cells survival

DOI 10.3892/ol.2018.7855

PMID 29541203

发布时间 2022-03-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Oncology letters

2018年15卷4期

4351-4357页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Transcriptome-derived stromal and immune scores infer clinical outcomes of patients with cancer.

Oncology letters

相似文献

Oncology letters

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Transcriptome-derived stromal and immune scores infer clinical outcomes of patients with cancer.

Oncology letters

相似文献

Oncology letters

相关期刊

检索历史清除